Thema: "Massively parallel in vivo screen identifies microRNAs that act synergistically with combinatorial immunotherapy for the treatment of liver cancer."

Referent: Prof. Dr. Klaus H. Kaestner, Department of Genetics and Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA

Zeit: Donnerstag, 23. April 2024, 16:30 Uhr s.t.

Ort: Universitätsklinikum Düsseldorf, Seminarraum des Leber- und Infektionszentrums, Gebäude 13.57, 2. OG, Seminarraum